Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles

ChemBioChem

Volumn 11, Issue 9, 2010, Pages 1273-1279

  Banerjee, Deboshri ^a   Liu, Allen P ^a   Voss, Neil R ^a   Schmid, Sandra L ^a   Finn, M G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Click chemistry; Polyvalency; Receptor mediated endocytosis; Transferrin; Viruses

Indexed keywords

ALKYNE; CLATHRIN; CLATHRIN LIGHT CHAIN; COPPER; GLYCAN; GREEN FLUORESCENT PROTEIN; LIGAND; OXIME; SIALIC ACID; TRANSFERRIN; TRANSFERRIN RECEPTOR; CAPSID PROTEIN;

ARTICLE; BACTERIOPHAGE; BINDING SITE; CATALYSIS; CONJUGATION; CYCLOADDITION; DENSITY; ENDOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; INTERNALIZATION; MOLECULAR RECOGNITION; NONHUMAN; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTUM YIELD; REACTION ANALYSIS; ULTRAVIOLET SPECTROSCOPY; UPREGULATION; VIRUS CAPSID; VIRUS LIKE AGENT; VIRUS PARTICLE; ALLOLEVIVIRUS; ANIMAL; CELL LINE; CHEMISTRY; FLOW CYTOMETRY; HAPLORHINI; HUMAN; METABOLISM;

ENTEROBACTERIOPHAGE QBETA; MIRIDAE;

ALKYNES; ALLOLEVIVIRUS; ANIMALS; CAPSID PROTEINS; CATALYSIS; CELL LINE; CLATHRIN; COPPER; ENDOCYTOSIS; FLOW CYTOMETRY; HAPLORHINI; HUMANS; LIGANDS; TRANSFERRIN;

EID: 77953374445     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201000125     Document Type: Article

References (47)

1. H. A. Huebers, C. A. Finch, Physiol. Rev. 1987, 67, 520.
2. G. J. Anderson, C. D. Vulpe, Cell. Mol. Life Sci. 2009, 66, 3241.
3. E. Ryschich, G. Huszty, H. P. Knaebel, M. Hartel, M. W. Buechler, J. Schmidt, Eur. J. Cancer 2004, 40, 1418.
4. a) T. R. Daniels, T. Delgado, G. Helguera, M. L. Penichet, Clin. Immunol. 2006, 121, 159;
5. b) T. R. Daniels, T. Delgado, J. A. Rodriguez, G. Helguera, M. L. Penichet, Clin. Immunol. 2006, 121, 144.
6. a) H. Li, Z. M. Qian, Med. Res. Rev. 2002, 22, 225;
7. b) H. Li, H. Sun, Z. M. Qian, Trends Pharmacol. Sci. 2002, 23, 206;
8. c) Z. M. Qian, H. Li, H. Sun, K. Ho, Pharmacol. Rev. 2002, 54, 561;
9. d) A. Widera, F. Norouziyan, W. C. Shen, Adv. Drug Delivery Rev. 2003, 55, 1439.
10. A. S. L. Derycke, A. Kamuhabwa, A. Gijsens, T. Roskams, D. de Vos, A. Kasran, J. Huwyler, L. Missiaen, P. A. M. de Witte, J. Natl. Cancer Inst. 2004, 96, 1620.
11. P.-H. Yang, X. Sun, J.-F. Chiu, H. Sun, Q.-Y. He, Bioconjugate Chem. 2005, 16, 494.
12. S. Sen Gupta, J. Kuzelka, P. Singh, W. G. Lewis, M. Manchester, M. G. Finn, Bioconjugate Chem. 2005, 16, 1572.
13. Q. Wang, E. Kaltgrad, T. Lin, J. E. Johnson, M. G. Finn, Chem. Biol. 2002, 9, 805.
14. a) E. Strable, M. G. Finn, Curr. Top. Microbiol. Immunol. 2009, 327, 1;
15. b) D. E. Prasuhn Jr. , P. Singh, E. Strable, S. Brown, M. Manchester, M. G. Finn, J. Am. Chem. Soc. 2008, 130, 1328.
16. a) G. T. Hermanson, Bioconjugate Techniques, 2nd ed., Academic Press, San Diego, 2008;
17. b) K. F. Geoghegan, J. G. Stroh, Bioconjugate Chem. 1992, 3, 138;
18. c) R. J. Goodson, N. V. Katre, Biotechnologia 1990, 8, 343.
19. a) S. Petren, O. Vesterberg, Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1989, 994, 161;
20. b) S. Welch in Transferrin: The Iron Carrier, CRC, Boca Raton, 1992, p. 253; The number of sialic acid groups on transferrin, as well as the total serum sialic acid level, is used as a diagnostic marker of alcoholism, see:
21. c) L. Chrostek, B. Cylwik, A. Krawiec, W. Korcz, M. Szmitkowski, Alcohol Alcohol. 2007, 42, 588-592.
22. Y. Beguin, G. Bergamaschi, H. A. Huebers, C. A. Finch, Am. J. Hematol. 1988, 29, 204.
23. a) Y. Cheng, O. Zak, P. Aisen, S. C. Harrison, T. Walz, J. Struct. Biol. 2005, 152, 204;
24. b) Y. Cheng, O. Zak, P. Aisen, S. C. Harrison, T. Walz, Cell 2004, 116, 565.
25. a) P. E. Dawson, S. B. H. Kent, Annu. Rev. Biochem. 2000, 69, 923;
26. b) A. Dirksen, T. M. Hackeng, P. E. Dawson, Angew. Chem. 2006, 118, 7743;
27. Angew. Chem. Int. Ed. 2006, 45, 7581.
28. V. Hong, S. I. Presolski, C. Ma, M. G. Finn, Angew. Chem. 2009, 121, 10063;
29. Angew. Chem. Int. Ed. 2009, 48, 9879.
30. S. D. Brown, J. D. Fiedler, M. G. Finn, Biochemistry 2009, 48, 11155.
31. R. A. Warren, F. A. Green, C. A. Enns, J. Biol. Chem. 1997, 272, 2116.
32. D. Loerke, M. Mettlen, D. Yarar, D. Jaqaman, H. Jaqaman, G. Danuser, S. L. Schmid, PLoS Biol. 2009, 7, e57.
33. H. M. Van der Schaar, M. J. Rust, C. Chen, H. Van der Ende-Metselaar, J. Wilschut, X. Zhuang, PLoS Pathog. 2008, 4, e1000244.
34. A. Ciechanover, A. L. Schwartz, A. Dautryvarsat, H. F. Lodish, J. Biol. Chem. 1983, 258, 9681.
35. For definitions and discussion of affinity and avidity in the context of polyvalent interactions, see: M. Mammen, S.-K. Choi, G. M. Whitesides, Angew. Chem. 1998, 110, 2908-2953;
36. Angew. Chem. Int. Ed. 1998, 37, 2754 -2794.
37. We also recommend the following paper for an excellent example of their application: E. Arranz-Plaza, A. S. Tracy, A. Siriwardena, J. M. Pierce, G.-J. Boons, J. Am. Chem. Soc. 2002, 124, 13035-13046.
38. E. W. Marsh, P. L. Leopold, N. L. Jones, F. R. Maxfield, J. Cell Biol. 1995, 129, 1509.
39. C. J. Lim, W. C. Shen, Pharm. Res. 2004, 21, 1985.
40. M. W. Goldberg, H. H. Lehr, M. Muller, (Hoffmann - La Roche), US patent 3398180, 1968.
41. O. Zak, K. Ikuta, P. Aisen, Biochemistry 2002, 41, 7416.
42. a) A. Dautry-Varsat, A. Ciechanover, H. F. Lodish, Proc. Natl. Acad. Sci. USA 1983, 80, 2258;
43. b) T. Hasegawa, E. Ozawa, Devel. Growth Differ. 1982, 24, 581.
44. C. Suloway, J. Pulokas, D. Fellmann, A. Cheng, F. Guerra, J. Quispe, S. Stagg, C. S. Potter, B. Carragher, J. Struct. Biol. 2005, 151, 41.
45. a) G. C. Lander, S. M. Stagg, N. R. Voss, A. Cheng, D. Fellmann, J. Pulokas, C. Yoshioka, C. Irving, A. Mulder, P.-W. Lau, D. Lyumkis, C. S. Potter, B. Carragher, J. Struct. Biol. 2009, 166, 95;
46. b) N. R. Voss, D. Lyumkis, A. Cheng, P.-W. Lau, A. Mulder, G. C. Lander, E. J. Brignole, D. Fellmann, C. Irving, E. L. Jacovetty, A. Leung, J. Pulokas, J. D. Quispe, H. Winkler, C. Yoshioka, B. Carragher, C. S. Potter, J. Struct. Biol. 2010, 169, 389.
47. S. J. Ludtke, P. R. Baldwin, W. Chiu, J. Struct. Biol. 1999, 128, 82.